Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Middle East Pharmaceutical Industries Company (4016.SR) Q3 2024 Earnings
4016.SR
-1.99%
5
Aug
Confirmed
Q2 2024
Q3 2024
999
333
-333
-999
Details
Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%
Description
Middle East Pharmaceutical Industries Company (4016.SR) will report earnings of for Q3 2024 on August 05, 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login